A detailed history of M&T Bank Corp transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, M&T Bank Corp holds 10,275 shares of PRCT stock, worth $648,969. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,275
Previous 10,513 2.26%
Holding current value
$648,969
Previous $440,000 15.23%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$40.38 - $50.75 $9,610 - $12,078
-238 Reduced 2.26%
10,275 $507,000
Q4 2023

Feb 06, 2024

BUY
$24.89 - $43.41 $39,599 - $69,065
1,591 Added 17.83%
10,513 $440,000
Q3 2023

Nov 02, 2023

BUY
$30.02 - $38.81 $267,838 - $346,262
8,922 New
8,922 $292,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $2.82B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track M&T Bank Corp Portfolio

Follow M&T Bank Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.